Related Experiment Video
Updated: Dec 14, 2025

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
Ploidy Leads a Molecular Motor to Walk Different Paths to Drug Resistance
Alexander M Real1, William M Marsiglia1, Arvin C Dar1
1Department of Oncological Sciences, Department of Pharmacological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract:
In this issue of Cell Chemical Biology, Pisa et al. (2020) find that haploid and diploid cells differentially develop resistance to the CENP-E inhibitor GSK923295. The results highlight the power of tumor cells to evade growth inhibition and potentially inform the design of next-generation CENP-E drugs to overcome resistance.
Insights
Haploid and diploid cells develop different resistance to the CENP-E inhibitor GSK923295. This finding reveals tumor cell adaptability and can guide the development of new drugs to overcome resistance.
Area of Science:
- Cell biology
- Cancer research
- Pharmacology
Background:
- Centromere-associated protein E (CENP-E) is a key motor protein in mitosis.
- Inhibitors of CENP-E are investigated as anti-cancer agents.
- Tumor cells can develop resistance to therapeutic agents.
Purpose of the Study:
- To investigate differential resistance mechanisms to the CENP-E inhibitor GSK923295 in haploid versus diploid cells.
- To understand how tumor cells evade growth inhibition by CENP-E inhibitors.
Main Methods:
- Cell culture experiments using haploid and diploid cell lines.
- Treatment with the CENP-E inhibitor GSK923295.
- Analysis of cell growth inhibition and resistance.
Main Results:
- Haploid and diploid cells exhibit distinct patterns of resistance to GSK923295.
- Tumor cells demonstrate a capacity to develop resistance to CENP-E inhibition.
- Differential resistance suggests distinct cellular pathways are involved.
Conclusions:
- Cellular ploidy influences the response to CENP-E inhibitors.
- Understanding resistance mechanisms is crucial for effective cancer therapy.
- Findings may inform the design of next-generation CENP-E inhibitors to overcome resistance.
Related Concept Videos
Treatment Resistant Cancers
Abnormal Proliferation
Nondisjunction
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Microtubule Associated Motor Proteins

